BioCryst Pharma (BCRX) PT Raised to $9 at RBC Capital
Tweet Send to a Friend
RBC Capital raised its price target on BioCryst Pharma (NASDAQ: BCRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
